Skip to main content
Search
search
Link to Facebook page
Link to X
Link to YouTube channel
Link to flipboard
Link to RSS
Main navigation
Home
About
About ACSH
Financials
Our Team
Video
Donate
Publications
Media/Contact
Subscribe
Write For Us
IRIS Toxicology Review
email
facebook
twitter
linkedin
pocket
reddit
print
Another View of EPA's Formaldehyde Review
It is difficult to understand how the EPA can continue to propose safe levels for chemicals such as formaldehyde that approach, or in some cases are lower than, levels that occur naturally or are produced in human metabolic pathways. This is
Read more
Is the EPA Really Following the Science on Formaldehyde?
Background on Formaldehyde
Read more
Subscribe to IRIS Toxicology Review
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
DONATE
Popular articles
Turmeric Supplements: More Risks Than Benefits
Podcast: Religion and Science—Friends, Enemies or Total Strangers?
From Death Sentence to Treatable Disease: A Conversation on Melanoma with Dr. Paul Chapman
Why Moms Matter: Loving Mothers Raise Healthy Children—Here's The Science
Podcast: Pesticides Killing Bees? Busting Chemical Myths With Dr. Liza Lockwood
ACSH Podcasts
Podcast: Pesticides Killing Bees? Busting Chemical Myths With Dr. Liza Lockwood
Podcast: Fight Drug Abuse With Safe Injection Sites? Dr. Lynn Webster
Podcast: Religion and Science—Friends, Enemies or Total Strangers?
Podcast: Fighting Schizophrenia—With Bacon? How Ketosis May (Or May Not) Help Treat Psychosis
Podcast: Can Everything Kill My Kids? Combating Viral Pseudoscience with Dr. Jess Steier
More podcasts
Latest from Josh
Why Some Beers Taste Better (or Worse) Than Others
Garden Grove Is Not East Palestine: Here's Why
Crazy Organic Chemicals From Mars
Can the Amino Acid Tyrosine Shorten Life?
More articles
Latest from Chuck
Coffee, Tea, Dementia, and Thee
From Death Sentence to Treatable Disease: A Conversation on Melanoma with Dr. Paul Chapman
ACSH Welcomes Dr. Katie Suleta
Greasing the Wheels – Medicare Advantages’ Middlemen
More articles